1. Advanced management of venous malformation with ethanol sclerotherapy: Mid-term results 
B.B. Lee, MD, FACSa, Y.S. Do, MDb, H.S. Byun, MDb, I.W. Choo, MDb, D.I. Kim, MDa, S.H. Huh, MDa 
Journal of Vascular Surgery 
Volume 37, Issue 3, Pages (March 2003)
DOI: /mva
Copyright © 2003 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions

2. Fig. 1
CVM demographic data on basis of Hamburg classification. *Five hundred twenty patients registered at Congenital Vascular Malformation Clinic, Vascular Center, Samsung Medical Center, Seoul, Korea (January 1995 to December 2000; 230 male and 290 female; mean age, 22.3 years; range, 2 months to 73 years). **Because of various factors, particularly young age, final diagnosis was temporarily deferred. It is, however, mostly venous malformations in addition to unclassifiable malformation from hemangioma.
Journal of Vascular Surgery  , DOI: ( /mva )
Copyright © 2003 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions

3. Fig. 2
VM demographic data on basis of location of lesions. *Two hundred twenty-six patients with VM, mostly infiltrating extratruncular form (83.2%) registered at Congenital Vascular Malformation Clinic, Vascular Center, Samsung Medical Center, Seoul, Korea (January 1995 to December 2000).
Journal of Vascular Surgery  , DOI: ( /mva )
Copyright © 2003 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions